Amphotericin B

What is Amphotericin B?

Amphotericin B is a potent and broad-spectrum antifungal medication primarily used to treat severe, life-threatening systemic fungal infections. Discovered in 1955, it belongs to a class of drugs known as polyene antibiotics. Due to its efficacy against a wide range of fungal pathogens, it is often considered a drug of choice for serious invasive mycoses, especially in immunocompromised patients where other treatments may be ineffective or contraindicated. While highly effective, conventional Amphotericin B is also known for its significant side effect profile. To mitigate some of these adverse effects, newer lipid formulations, such as liposomal Amphotericin B and Amphotericin B lipid complex, have been developed, offering improved safety and tolerability while maintaining potent antifungal activity.

This medication is not absorbed orally and must be administered intravenously. Its use is typically reserved for severe infections due to its potential for toxicity, making careful patient selection and monitoring crucial during treatment.

How Does it Work?

The mechanism of action of Amphotericin B involves targeting the fungal cell membrane. Specifically, Amphotericin B binds to ergosterol, a sterol unique to the fungal cell membrane, which is structurally analogous to cholesterol in human cell membranes. Upon binding to ergosterol, Amphotericin B molecules aggregate and form pores or channels within the fungal cell membrane. These pores disrupt the integrity of the membrane, leading to an increase in its permeability. This allows for the leakage of essential intracellular components, such as potassium ions, amino acids, and other metabolites, out of the fungal cell.

The loss of these vital cellular constituents disrupts the metabolic processes of the fungus, ultimately leading to fungal cell death. This fungicidal action makes Amphotericin B highly effective against a broad spectrum of fungal pathogens. While it primarily targets ergosterol, some interaction with human cholesterol can occur, contributing to its associated toxicity.

Medical Uses

Amphotericin B is indicated for the treatment of a wide array of severe and potentially life-threatening fungal infections. Its broad spectrum of activity makes it valuable in situations where the causative fungus is unknown or when other antifungal agents have failed. Key medical uses include:

• Invasive Candidiasis: Including candidemia and deep-seated candidal infections in various organs.
• Aspergillosis: Particularly invasive aspergillosis, often seen in immunocompromised individuals.
• Cryptococcosis: Including cryptococcal meningitis, especially in HIV-infected patients, often in combination with flucytosine.
• Blastomycosis: Severe pulmonary and disseminated forms.
• Histoplasmosis: Severe and disseminated disease.
• Coccidioidomycosis: Severe pulmonary, disseminated, or meningeal forms.
• Mucormycosis (Zygomycosis): A rapidly progressive and often fatal infection, where Amphotericin B is a primary treatment.
• Leishmaniasis: In some forms, particularly visceral leishmaniasis, liposomal Amphotericin B is a treatment option.

Its use is generally restricted to patients with progressive, potentially fatal infections where the benefits outweigh the significant risks of adverse effects.

Dosage

The dosage of Amphotericin B varies significantly depending on the specific formulation (conventional vs. lipid formulations), the type and severity of the fungal infection, the patient's condition, and their tolerance to the medication. It is always administered intravenously (IV) and requires careful calculation and monitoring by healthcare professionals.

• Conventional Amphotericin B (Amphotericin B deoxycholate): Doses typically range from 0.25 mg/kg/day to 1.5 mg/kg/day, infused slowly over 2-6 hours. A test dose is often administered prior to the first full dose to assess patient tolerance.
• Lipid Formulations (e.g., Liposomal Amphotericin B, Amphotericin B Lipid Complex): These formulations allow for higher doses with a reduced risk of toxicity, especially nephrotoxicity. Doses can range from 3 mg/kg/day to 6 mg/kg/day, also administered via slow IV infusion.

Treatment duration can range from weeks to several months, depending on the infection. Due to the potential for severe side effects, patients receiving Amphotericin B require close medical supervision, including frequent monitoring of renal function, electrolytes, and liver function tests.

Side Effects

Amphotericin B is notorious for its significant side effect profile, which can limit its use despite its efficacy. The lipid formulations were developed to mitigate some of these toxicities, but side effects can still occur. Common side effects include:

• Infusion-Related Reactions: These are very common, especially with conventional Amphotericin B, and can occur within 1-3 hours of infusion. Symptoms include fever, chills, rigors, headache, nausea, vomiting, myalgia, arthralgia, and hypotension. Pre-medication with antipyretics, antihistamines, or corticosteroids can help manage these reactions.
• Nephrotoxicity: Kidney damage (nephrotoxicity) is a major dose-limiting toxicity. It can manifest as elevated serum creatinine and blood urea nitrogen (BUN), and electrolyte abnormalities (hypokalemia, hypomagnesemia). Hydration with saline can help reduce the risk.
• Electrolyte Imbalances: Hypokalemia (low potassium) and hypomagnesemia (low magnesium) are frequent and can be severe, often requiring supplementation.
• Hematological Effects: Anemia (normochromic, normocytic) is common due to suppression of erythropoietin production. Thrombocytopenia and leukopenia are less common.
• Hepatotoxicity: Liver enzyme elevations can occur but are generally less common and less severe than renal toxicity.

Close monitoring of renal function, electrolytes, and complete blood counts is essential throughout treatment.

Drug Interactions

Amphotericin B can interact with several other medications, potentially increasing toxicity or altering drug efficacy. It is crucial to inform your doctor about all medications you are taking, including over-the-counter drugs and herbal supplements.

• Nephrotoxic Drugs: Concomitant use with other nephrotoxic agents (e.g., cyclosporine, tacrolimus, aminoglycosides, non-steroidal anti-inflammatory drugs (NSAIDs), cisplatin) significantly increases the risk of Amphotericin B-induced nephrotoxicity.
• Corticosteroids and Corticotropin: These can enhance potassium depletion caused by Amphotericin B, increasing the risk of cardiac arrhythmias.
• Diuretics: Thiazide and loop diuretics can increase the risk of hypokalemia and hypomagnesemia.
• Flucytosine: While often used in combination for synergistic antifungal effects, Amphotericin B can increase the cellular uptake and toxicity of flucytosine, particularly in patients with impaired renal function.
• Muscle Relaxants: Amphotericin B-induced hypokalemia can potentiate the effects of skeletal muscle relaxants (e.g., tubocurarine), leading to prolonged paralysis.
• Digoxin: Hypokalemia caused by Amphotericin B can increase the risk of digoxin toxicity.
• Antineoplastic Agents: Concomitant use may increase the risk of renal toxicity, bronchospasm, and hypotension.

Careful monitoring and dose adjustments may be necessary when Amphotericin B is administered with these medications.

FAQ

Q: What is the difference between conventional and liposomal Amphotericin B?

A: Conventional Amphotericin B (deoxycholate) is the original formulation and is known for higher rates of infusion-related reactions and nephrotoxicity. Liposomal Amphotericin B and other lipid formulations encapsulate the drug in a lipid layer, which delivers the drug more selectively to fungal cells and reduces exposure to human tissues. This generally results in fewer side effects, especially less nephrotoxicity, allowing for higher doses and better tolerability.

Q: Is Amphotericin B safe for everyone?

A: No. Due to its significant side effect profile, particularly kidney toxicity, Amphotericin B is generally reserved for severe, life-threatening fungal infections where its benefits outweigh the risks. It requires careful monitoring and is used with caution in patients with pre-existing kidney disease or other comorbidities.

Q: How is Amphotericin B administered?

A: Amphotericin B is administered only by intravenous (IV) infusion, typically over several hours. It is not absorbed orally and cannot be given via other routes for systemic infections.

Q: What should I do if I miss a dose of Amphotericin B?

A: If you miss a dose, you should contact your doctor or healthcare provider immediately. They will advise you on the appropriate course of action, as treatment schedules for severe infections are critical.

Products containing Amphotericin B are available through trusted online pharmacies. You can browse Amphotericin B-based medications at ShipperVIP or Medicenter.

Summary

Amphotericin B remains a cornerstone in the treatment of severe and life-threatening systemic fungal infections. Its powerful fungicidal action, achieved by disrupting the fungal cell membrane, makes it indispensable against a broad range of pathogens. While the conventional formulation is associated with significant adverse effects, notably nephrotoxicity and infusion-related reactions, the development of lipid formulations has significantly improved its safety profile and tolerability. Despite these advancements, its administration requires meticulous medical supervision, careful dosage adjustment, and vigilant monitoring of renal function and electrolytes. As a critical antifungal medication, Amphotericin B continues to save lives, especially in immunocompromised patients, underscoring its enduring importance in infectious disease management.